Sales Growth YoY (Last Twelve Months): Corcept Therapeutics Corp (CORT)

Graphic logo of Corcept Therapeutics Corp (CORT)

Corcept Therapeutics (CORT) dominates the cortisol receptor modulation segment, possessing absolute pricing power. Sales volume growth compared to the same period last year over the past 12 months confirms this status, and 30.40 reflects the latest value of the metric. However, reliance on a single drug and the risk of generics create vulnerability. Stable demand for endocrine therapy currently provides the company with a reliable cash flow.

Sales Growth YoY (Last Twelve Months): Corcept (CORT) for 02/11/2024 - 11/18/2026

Corcept Therapeutics Inc. (CORT) - metric breakdowns and financial figures

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Analysis of all company metrics:Corcept Therapeutics
Mass-produced product of Corcept Therapeutics Incorporated

Corcept Therapeutics (CORT) specializes in biopharmaceuticals, implementing "green chemistry" principles to optimize resources during drug synthesis. This indicator reflects revenue dynamics over the last twelve months relative to the same period last year. It is critical for investors to assess the sustainability of this growth as confirmation of market demand for the drugs. Analyzing the company's TTM annual revenue growth rate helps identify risks of asset overheating or capital stagnation.

Competitors of Corcept Therapeutics (CORT)

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (Last Twelve Months)|AKRO: Sales Growth YoY (TTM)|MTSR - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) MoonLake Corp|Crinetics Corp (CRNX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) newamsterdampharma.com (NAMS)|Revenue Growth YoY (Last 12 Months) soleno.life SLNO|Sales Growth YoY (TTM) FOLD (amicusrx.com)|Annual Revenue Growth (Last Twelve Months) 89bio (ETNB)|Agios - Sales Growth YoY (TTM)|Structure Corp - Revenue Change YoY (Last 12 Months)|mimedx.com (MDXG) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Sales Growth RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) MBX|Sales Growth YoY (Last Twelve Months) Altimmune Pharma (ALT)|Sales Growth YoY (Last Twelve Months) AARD (Aardvark Therapeutics Corp)|Sales Growth YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Trailing Twelve Months Revenue Growth|BMEA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Revenue Growth YoY (Last 12 Months)|vTv Therapeutics, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Agape ATP Corp.|Revenue Growth YoY (Last 12 Months) Pluri (PLUR)|Sales Growth YoY (TTM) SYBX|Annual Revenue Growth (Last Twelve Months) Lipocine Inc|Sales Growth YoY (Last Twelve Months) Matinas BioPharma Holdings MTNB|Annual Revenue Growth (Last Twelve Months) Spruce Biosciences (SPRB)|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)